HR 5279
116th Congress
House
Health
Animal protection and human-animal relationships
Business records
Congressional oversight
Consumer affairs
Cosmetics and personal care
Drug safety, medical device, and laboratory regulation
Government information and archives
Inflation and prices
Internet and video services
Internet, web applications, social media
Licensing and registrations
Manufacturing
Performance measurement
Product safety and quality
User charges and fees
Cosmetic Safety Enhancement Act of 2019
Introduced: December 3, 2019
Introduced by:
Pallone, Frank
Democratic
· New Jersey
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
Dec 4, 2019
Referred to the Subcommittee on Health.
Dec 3, 2019
Introduced in House
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
Plain-English summary
Cosmetic Safety Enhancement Act of 2019
This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.
What's happening now
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Committees of jurisdiction
2